Back to search

France· FR:68485478

LEVODOPA/CARBIDOPA/ENTACAPONE BIOGARAN 175 mg/43,75 mg/200 mg, comprimé pelliculé

A medicinal product containing lévodopa + carbidopa + entacapone, registered in France by BIOGARAN, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLEVODOPA/CARBIDOPA/ENTACAPONE BIOGARA…ATC—REGISTER NO.FR:68485478PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LÉVODOPA + CARBIDOPA + ENTACAPONE
Manufacturer
BIOGARAN
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400928011299
    flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)
    EUR 48.62

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lévodopa + carbidopa + entacapone in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lévodopa + carbidopa + entacapone products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Levodopa/Carbidopa/Entacapon Rivopharm, Sastravi
  • Belgium · Levodopa/Carbidopa/Entacapone Eg
  • Czechia · Stacapolo
  • Germany · Levodopa/Carbidopa/Entacapon Abz, Levodopa/Carbidopa/Entacapon Al
  • Denmark · Levodopa/Carbidopa/Entacapone Holsten, Pentiro
  • Estonia · Levodopa/Carbidopa/Entacapone Teva
  • Spain · Levodopa/Carbidopa/Entacapona Cinfa, Levodopa/Carbidopa/Entacapona Kern Pharma
  • Finland · Pentiro
  • United Kingdom (Northern Ireland) · Sastravi, Stacar
  • Hungary · Levodopa/Carbidopa/Entacapone Teva, Sastravi
  • Ireland · Sastravi
  • Iceland · Corbilta, Levodopa/Carbidopa/Entacapone Orion
  • Italy · Carbidopa-Entacapone-Levodopa Teva, Levodolevodopa/Carbidopa/Entacapone Teva
  • Liechtenstein · Corbilta, Levodopa/Carbidopa/Entacapone Orion
  • Luxembourg · Levodopa/Carbidopa/Entacapone Eg
  • Latvia · Levodopa/Carbidopa/Entacapone Teva
  • Netherlands · Levodopa/Carbidopa/Entacapone Teva
  • Norway · Corbilta, Levodopa/Carbidopa/Entacapone Orion
  • Portugal · Levodopa + Carbidopa + Entacapona Farmoz, Levodopa + Carbidopa + Entacapona Generis
  • Romania · Levodopa/Carbidopa/Entacaponă Teva
  • Sweden · Levodopa/Carbidopa/Entacapone Holsten, Levodopa/Carbidopa/Entacapone Stada Arzneimittel Ag
  • Slovenia · Tapidola
  • Slovakia · Levodopa/Carbidopa/Entacapone Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb611f54-795b-46bb-b6aa-b3a31ac54a6a
GET /v1/drugs/cb611f54-795b-46bb-b6aa-b3a31ac54a6a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68485478",
  "date_amm": "2014-12-12",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "LÉVODOPA + CARBIDOPA + ENTACAPONE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about lévodopa + carbidopa + entacapone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.